Jewett Anahid
Division of Oral Biology and Medicine, The Jane and Jerry Weintraub Center for Reconstructive Biotechnology, UCLA, Los Angeles, CA; The Jonsson Comprehensive Cancer Center, UCLA School of Dentistry and Medicine, Los Angeles, CA.
Crit Rev Immunol. 2020;40(2):167-171. doi: 10.1615/CritRevImmunol.2020034441.
Coronavirus disease 2019 (COVID-19) poses a great public health challenge worldwide. While studies on the effects of SARS-CoV-2 on immune cell function continue to progress, we know very little about the significance of depletion of key immune effectors by the virus in the mortality and morbidity of the disease. This commentary reviews what is known thus far about the effects of the virus on natural killer (NK) cells, the major cell type responsible for the destruction and removal of virally infected cells. It also highlights the necessity of comprehensive studies of NK cells in COVID-19 patients and animal models to better understand the role and significance of reported NK depletion and functional inactivation in disease morbidity and mortality, in the hopes of designing effective therapeutic interventions for the disease.
2019冠状病毒病(COVID-19)在全球范围内构成了巨大的公共卫生挑战。虽然关于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)对免疫细胞功能影响的研究仍在不断推进,但我们对该病毒导致关键免疫效应因子耗竭在疾病死亡率和发病率方面的意义知之甚少。本述评回顾了迄今为止已知的该病毒对自然杀伤(NK)细胞的影响,NK细胞是负责破坏和清除病毒感染细胞的主要细胞类型。它还强调了对COVID-19患者和动物模型中的NK细胞进行全面研究的必要性,以便更好地理解所报道的NK细胞耗竭和功能失活在疾病发病率和死亡率中的作用及意义,以期为该疾病设计有效的治疗干预措施。